jurnalul român de psihofarmacologie romanian journal of ...

42. Casey DE. Side effects profiles of new antipsychotic agents. J Clin Psychiatry 1996;
57(Suppl. 11):40-45, Discussion 46-52.
43. Delcker A, Schoon ML, Oczkovsky B, Gaertner HJ. Amisulpride versus haloperidol in
treatment of schizophrenic patients: results of a double-blind study.
Pharmacopsychopsychiatry 1990; 23:125-130.
44. Peuch A, Fleurot O, Rein W. Amisulpride, an atypical antipsychotic, in the treatment of
acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. Acta Psychiatr Scand
1998; 98:65-72.
45. Moeller HJ, Boyer P, Fleurot O, Rein W. Improvement of acute exacerbations of
schizophrenia with amisulpride: a comparison with haloperidol. Psychopharmacology
1997; 132:396-401.
46. Carriere P, Bonhomme D, Lemperiere T. Amisulpride has a superior benefit/risk profile to
haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride
Study Group). Eur Psychiatry 2000; 15:321-329.
47. Wetzel H, Grunder G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adier G, Shroder J, Rein
W, Benkert O. Amisulpride versus flupenthixol in schizophrenia with predominantly
positive symptomatology: a double-blind controlled study comparing a selective D2-like
antagonist to a mixed D1/D2-like antagonist. Psychopharmacology 1998; 137:223-232.
48. Pichot P, Boyer P. A double-blind, controlled, multicenter trial of low dose amisulpride
(Solian 50) versus low dose fluphenazine in the treatment of negative symptoms in chronic
schizophrenia. Ann Psychiatr 1988; 3:312-320.
49. Peuskens J, Bech P, Moeller HJ, Bale R, Fleurot O, Rein W. Amisulpride vs risperidone in
the treatment of acute exacerbations of schizophrenia. Amisulpride Study Group.
Psychiatry Res 1999; 88:107-117.
50. Speller JC, Barnes TR, Curson DA, Pantelis C, Alberts JL. One-year, low-dose neuroleptic
study of in-patients with chronic schizophrenia characterized by persistant negative
symptoms. Amisulpride vs haloperidol. Br J Psychiatry 1997; 171:564-568.
51. Saletu B, Kufferle B, Grundberger J, Foldes P, Topitz A, Anderer P. Clincal, EEG mapping
and psychometric studies in negative schizophrenia: comparative trial with amisulpride and
fluphenazine. Neuropsychobiology 1994; 29:125-130.
52. Lecrubier Y, Boyer P, Turjanski S, Rein W. Amisulpride versus imipramine and placebo in
dysthymia and major depression. Amisulpride Study Group. J Affect Disord 1997; 43:95-103.
53. Ravizza L. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind
safety study versus amitriptyline. AMILONG Investigators. Psychopharmacology 1999;
13:248-254.
136